Key Insights

Highlights

Success Rate

85% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

9.2%

6 terminated out of 65 trials

Success Rate

85.4%

-1.1% vs benchmark

Late-Stage Pipeline

22%

14 trials in Phase 3/4

Results Transparency

17%

6 of 35 completed with results

Key Signals

6 with results85% success

Data Visualizations

Phase Distribution

56Total
Not Applicable (22)
P 1 (5)
P 2 (15)
P 3 (13)
P 4 (1)

Trial Status

Completed35
Unknown12
Terminated6
Withdrawn4
Not Yet Recruiting4
Active Not Recruiting3

Trial Success Rate

85.4%

Benchmark: 86.5%

Based on 35 completed trials

Clinical Trials (65)

Showing 20 of 20 trials
NCT07565415Phase 2Not Yet Recruiting

Nanocrystalline Megestrol Acetate Versus Placebo for Anorexia in Patients With Unresectable Hepatocellular Carcinoma Receiving TACE Combined With Targeted and Immunotherapy

NCT03637816Phase 2Active Not RecruitingPrimary

Anamorelin Hydrochloride in Reducing Anorexia in Patients With Advanced Non-small Cell Lung Cancer

NCT04939090Phase 3Active Not Recruiting

Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients

NCT00488072Phase 2Active Not Recruiting

Effects of Mirtazapine on Appetite in Advanced Cancer Patients

NCT07179094Not ApplicableNot Yet Recruiting

The Effect of a Protective Oral Care Protocol Using Peppermint Oil Mouthwash

NCT06593366Not ApplicableNot Yet Recruiting

Fecal Microbiota Transplant for Anorexia Nervosa

NCT06154525Not ApplicableCompleted

Effectiveness of Bacillus Spore Probiotics in Reducing Constipation, Anorexia, and Slow Weight Gain in Children

NCT05243251Phase 3CompletedPrimary

Olanzapine Anorexia Cachexia

NCT06517199Phase 3RecruitingPrimary

Olanzapine for Cancer Related Anorexia-cachexia Syndrome

NCT04803305Phase 1Completed

Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia

NCT06146075Not Yet RecruitingPrimary

Insights Into Participating in Clinical Studies for Anorexia

NCT03097874Not ApplicableCompleted

Adaptive Treatment for Adolescent Anorexia Nervosa

NCT03283488Phase 2Completed

Comparison Between Mirtazapine and Megestrol for the Control of Anorexia-cachexia in Cancer Patients in Palliative Care.

NCT04748523Not ApplicableCompletedPrimary

Effect of Mirtazapine Versus Placebo in Patients With Non-small Cell Lung Cancer and Anorexia

NCT04007900Not ApplicableCompleted

Positive Affect Treatment (PAT) to Target Reward Mechanisms in Anorexia Nervosa

NCT05708404CompletedPrimary

Outpatient Treatment of Severe and Enduring Anorexia Nervosa

NCT02050490Completed

Effect of a Symptom Diary on Symptom Care and Symptom Burden in Patients Treated With Chemotherapy: a Before-and-after-study

NCT04220112Not ApplicableCompletedPrimary

Comparing Real-time fMRI Neurofeedback Versus Sham for Altering Limbic and Eating Disturbances in Anorexia Nervosa

NCT02830620Not ApplicableCompleted

Study at the Man of the Profile of Chimiokines in the Anorexia Bound to the Cancerous Cachexy

NCT05503147Phase 1Unknown

Sativex® and Gentamicin for Optimized Pharmagological Treatment in Older Patients (CanPan)

Scroll to load more

Research Network

Activity Timeline